{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:22:33Z","timestamp":1761294153294,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.arteri.2020.06.003","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T02:41:09Z","timestamp":1593657669000},"page":"278-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Estatinas en COVID-19: \u00bfexiste alg\u00fan fundamento?"],"prefix":"10.1016","volume":"32","author":[{"given":"Marcos M.","family":"Lima Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleskha","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"D\u2019Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2020.06.003_bib0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arteri.2020.06.003_bib0125","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2020.06.003_bib0130","first-page":"69","article-title":"Inmune modulatory effects of statins","volume":"154","author":"Zeiser","year":"2018","journal-title":"Inmunology."},{"key":"10.1016\/j.arteri.2020.06.003_bib0135","first-page":"e102","article-title":"Cardiovascular disease, drug therapy, and mortality in Covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2020.06.003_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","article-title":"Treating influenza with statins and other immunomodulatory agents","volume":"99","author":"Fedson","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.arteri.2020.06.003_bib0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/14787210.2018.1512403","article-title":"Severe community-acquired pneumonia: current management and future therapeutic alternatives","volume":"16","author":"Garnacho-Montero","year":"2018","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.arteri.2020.06.003_bib0150","first-page":"3","article-title":"Sistema renina angiotensina y riesgo cardiometab\u00f3lico. Revisi\u00f3n","volume":"8","author":"Lima","year":"2010","journal-title":"Rev Venez Endocrinol Metab."},{"key":"10.1016\/j.arteri.2020.06.003_bib0155","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1096\/fj.202000782","article-title":"Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: a double-edged sword?","volume":"34","author":"Yan","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.arteri.2020.06.003_bib0160","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res."},{"key":"10.1016\/j.arteri.2020.06.003_bib0165","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem."},{"key":"10.1016\/j.arteri.2020.06.003_bib0170","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2020.06.003_bib0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.arteri.2020.06.003_bib0180","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1016\/j.arteri.2020.06.003_bib0185","doi-asserted-by":"crossref","first-page":"e00638","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-like receptor 3 signalling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"mBio."},{"key":"10.1016\/j.arteri.2020.06.003_bib0190","doi-asserted-by":"crossref","first-page":"e1000240","DOI":"10.1371\/journal.ppat.1000240","article-title":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV","volume":"4","author":"Sheahan","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.arteri.2020.06.003_bib0195","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/JVI.02576-13","article-title":"Inhibition of NF-\u03baB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival","volume":"88","author":"DeDiego","year":"2014","journal-title":"J Virol."},{"key":"10.1016\/j.arteri.2020.06.003_bib0200","first-page":"49","article-title":"Atorvastatin attenuates TLR4-mediated NF-kappa B activation in a MyD88-dependent pathway","volume":"27","author":"Chansrichavala","year":"2009","journal-title":"Asian Pac J Allergy Immunol."},{"key":"10.1016\/j.arteri.2020.06.003_bib0205","doi-asserted-by":"crossref","first-page":"e00398","DOI":"10.1128\/mBio.00398-20","article-title":"Hiding in plain sight: an approach to treating with severe COVID-19 infection","volume":"11","author":"Fedson","year":"2020","journal-title":"mBio."},{"key":"10.1016\/j.arteri.2020.06.003_bib0210","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvaa042","article-title":"Statin therapy in COVID-19 infection","author":"Castiglione","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"10.1016\/j.arteri.2020.06.003_bib0215","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: in silico evidence on direct interaction","volume":"16","author":"Reiner","year":"2020","journal-title":"Arch Med Sci."},{"key":"10.1016\/j.arteri.2020.06.003_bib0220","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.arteri.2020.06.003_bib0225","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American Heart Association","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2020.06.003_bib0230","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","article-title":"Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity","volume":"126","author":"Chalasani","year":"2004","journal-title":"Gastroenterology."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916820300632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916820300632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:32:09Z","timestamp":1759325529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916820300632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0214916820300632"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2020.06.003","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estatinas en COVID-19: \u00bfexiste alg\u00fan fundamento?","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2020.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}